CURRICULUM VITAE - Geisinger Health System

CURRICULUM VITAE
Name:
Address (work):
Marius SUDOL
Weis Center for Research
Geisinger Clinic
100 North Academy Avenue
Danville, PA 17822-2608
Telephone: (570) 271-6677
Fax (570) 271-6701
E.mail:
msudol1@geisinger.edu
Citizenship:
U.S.A.
Research Aims:
Employ tools of molecular biology, biochemistry, structural biology and
bioinformatics to understand:
signal transduction networks that use modular protein domains,
genetic lesions affecting modular domains and resulting in human diseases,
contribution of the WW domain to the function of the human proteome,
and design strategies for rational, therapeutic interventions based on the
detailed knowledge of the structure and function of protein modules

Education and Training:
1973-1978: Jagiellonian University, Krakow, Poland, Master of Science,
Molecular Biology, Laboratory of Dr. A. Klein
1978-1983: The Rockefeller University, New York, Ph.D
Cellular and Molecular Biology, Laboratory of Dr. E. Reich
1983-1987: The Rockefeller University, New York, Postdoctoral Training,
Viral Oncology, Laboratory of Dr. H. Hanafusa
Academic Appointments:
1987-1995: The Rockefeller University, New York, NY
Assistant Professor, Laboratory of Molecular Oncology
1995-2004: The Mount Sinai School of Medicine, New York, NY
Associate Professor, Department of Medicine
2004-present: The Mount Sinai School of Medicine, New York, NY,
Adjunct Associate Professor, Department of Medicine
2004-present: Weis Center for Research, Danville, PA,
Staff Scientist, Laboratory of Signal Transduction
and Proteomic Profiling
Honors, Citations, Fellowships and Selected Grant Awards:
Winner of the National Competition in Biology for High School Students (Warsaw, 1972)
Honors at Entrance (Jagiellonian University, 1973)
Dean Prizes for Academic Excellence (1974, 1975, 1976, 1977)
Graduated Magna Cum Laude, Jagiellonian University (1978)
Graduate Student Fellowship from Merinoff Cancer Fund (1982-1983)
Damon Runyon-Walter Winchell Cancer Fund Fellowship (1983-1985)
Junior Faculty Research Award from American Cancer Society (1987-1990)
FIRST NIH Grant Award from National Cancer Institute (1987-1992)
Klingenstein Award in the Neurosciences (1991-1994)
NIH Research Career Development Award from National Cancer Institute (1991-1996)
Human Frontier Science Program Grant (1993-1996)
Grant from Rhone-Poulenc Rorer Pharmaceutical Co., (1997-1999)
Grant from Muscular Dystrophy Association (1995-2001)
NIH PPG on Gene Therapy (1997-2001)
Alzheimer’s Association Grant (1999-2002)
NIH RO1 on Dystrophin WW domain (2000-2003)
Human Frontier Science Program Grant (with Stan Fields); Second Award (2000-2003)
NIH PPG on Function of PKD1Gene (2003-2008)
Breast Cancer Coalition of PA Grants (2007-2008, 2008-2009, 2010-2011)
Editorial Boards:
(1995-2004) Editorial Board Member of Archives of Biochemistry and Biophysics
(2000-2009) Editorial Board Member of Virology

(2003-2004) Editorship of a book entitled: “Modular Protein Domains” (Publisher: Wiley-
VCH, Verlag GmbH & Co., KGaA, Weinheim, Germany) Editors: Gianni Cesareni
(University of Rome, Tor Vergata, Italy); Mario Gimona (University of Salzburg, Austria);
Marius Sudol, (Geisinger, USA); Michael Yaffe (MIT, USA)
(2010-2011) Editorship of Hanafusa Memorial issues (2) of “Genes and Cancer” Journal,
which featured a series of research reviews on cancer signaling. Editors: Irwin Gelman
(Roswell Park Cancer Center, Buffalo, NY) and Marius Sudol (Geisinger, USA)
(2010-present) Editorial Board Member of Oncogene
(2012) Special Issue of FEBS Letters on “Modular Protein Domains”. Editors: Gianni
Cesareni (University of Rome, Tor Vergata, Italy), Wilhelm Just (University of
Heidelberg, Germany), Giulio Superti-Furga (Center for Molecular Medicine, Austria) and
Marius Sudol (Geisinger, USA)
(2012-present) Board of Reviewing Editors (BoRE) for Science Signaling
(2013-2018) Journal of Biological Chemistry, Editorial Board Member
Ad hoc reviewer for major journals including Cell, Neuron, Nature, Science, EMBO, J
JBC, JCB, PLoS Biology, PLoS ONE, MCB and MBC
Advisory Panels/Grant Review/Function of Consultant:
1996-2000 Consultant for the Graduate Program at the University of Mexico, Mexico
1996-2003 Human Frontier Science Program Organization, Strasbourg, France
1997-1998 Burroughs Wellcome Fund of the United Kingdom
1997-1999 National Science Foundation
1997-2002 Alzheimer Association, USA (Chicago)
1997-2003 Scientific Consultant for AxCell/Cytogen Biotech Company, Princeton, NJ
1998-2000 Cancer Research Institute of Italy
2000 Reviewer for Henry Ford Health Grants
2000 Adviser for the ERATO Program of Japan
2000-2003 Scientific Consultant for Signal Pharmaceuticals Inc., now Celgene
2003 Award Advisory Committee at the University of Seoul, South Korea
2003 Advisory Function for Grant and Ph.D. defense at Univ. of Singapore, Singapore
2003-pres. MIUR (Ministry of Education, Italy) Research Grant Review Panel
2008 Reviewer of grants for Regina Elena Cancer Institute, Rome, Italy
2008 Evaluation of a candidate for Erwin Schroedinger Prize, Germany, Helmholtz Soc.
2009 Evaluation of a cancer research proposal for DKFZ-MOST, Germany-Israel
2009 Evaluation of a grant proposal Ohio Cancer Research Associates
2009 Evaluation of a grant for Minerva Foundation (Germany)
2010 Evaluation of a grant from the NMRC of Singapore
2010 Study Section for PA-BCC (Breast Cancer Coalition of Pennsylvania)
2011 Evaluation of a grant for HFSPO
2011 Study Section for PA-BCC (Breast Cancer Coalition of Pennsylvania)
2012 Evaluation of 3 grants from the NMRC of Singapore
2012 Evaluation of a grant for USA-Israel Research Foundation

2012 Evaluation of a grant from Academy of Sciences of Czech Republic
2012 DOD-Idea Award, Breast Cancer Study Section, Reston VA, October 10-12
2013 Evaluation of a grant from National Science Center, Krakow, Poland
Training Record:
Outstanding Technicians, Summer Students and Westinghouse Competition Finalists:
Atom Sarkar: 1986-87: now a practicing M.D., a neurosurgeon and neuroscience researcher
at Geisinger, PA
Caren Kieswetter: 1988-1989: now an M.D. and Medical Officer at the FDA, Washington D.C.
Lucy Shigemitsu: 1989: Westinghouse Competition Finalist in Washington D.C.- now a
corporate lawyer, New York.
Aaron Einbond: 1996: Westinghouse Competition Finalist in Washington D.C. – now a
postdoctoral fellow in Music Department at Columbia University, NY.
Other Summer Students and/or Westignhouse Competitors (1989-2011): Michael Grinshtein;
Suzie Ariyatana; Nora Hakim, Seth Birnbaum, Deborah Loo, Karama Neal, Philip Wellner,
Kirsten Price, Lori Newman; Antonio Torres; Jasmin Bejerano, Kate Biblowitz, Jasmin
Hernandez, Christian Plaas; Licelot Eralte-Mercer, Jennifer Abraczinskas, Adam Satteson,
Allison Young, Benjamin Foster, Priya Raghavan, Ryan Jones, Amanda Pulsifer, Kristin
Berger.
PhD-MD
Students Including Rotating MD/.Ph.D. Students:
Evan Kaiser: 1988; Emily Chan:1990; The Rockefeller University Ph.D. students: Y-H. Zhao,
K. Fang and H. Greulich were co-advised in collaboration with Dr. H. Hanafusa, the head of
the laboratory of Molecular Oncology. Yu-Hang Zhao: (Ph.D. Rockefeller University 1992)
Thesis: “Expression of Proto-oncogene YES in Mammalian Tissues and Calcium-Induced
Inactivation of Its Kinase in Keratinocytes”. - Now a business administrator, Connecticut.
Kathy Fang: (Ph.D. Rockefeller University 1994) Thesis: “Role of protein tyrosine
phosphatases in signaling by receptor tyrosine kinases” - Now a dermatologist at the
University of California, Davis. Heidi Greulich: (Ph.D. Rockefeller University 1995) Thesis:
“Signaling by Crk oncogene involves MAP kinase”. – Now a researcher at the Broad Institute,
Boston, MA. Henry Chen: (Ph.D. Rockefeller University 1997) MD/Ph.D. student. Thesis: “The
WW Domain: Characterization of a Novel Protein Interaction Module and Its Role in Signal
Transduction”. – Now a practicing M.D. at Houston, Texas..
Students at Mount Sinai Med. Center:
Kira Ermekova-Shienerman: 1995-2000, Ph.D.: Thesis: “FE65 and its WW Domain; Signaling
in Alzheimer’s Disease”. Paola di Candia: 1996; visiting Ph.D. student; Stacey Rentschler:
1996 rotating MD/Ph.D student; Alex Chang: 1996-2000 Ph.D. Mount Sinai: “Role of the WW
domain in nuclear processes”. Katrin Deininger: 1998 rotating Ph.D. student; Giuseppina
Minopoli: 1999 - visiting Ph.D. student; Caterina Venturelli, 1996-2001, Ph.D. Thesis:
“Molecular Analysis of WW Domain Protein IQ-GAP in Hydra” The University of Mexico, Coadviser
with Dr. Luis Salgado. Haibo Zhang, 2002-2004 Ph.D. student at The Rutgers
University working on bioinformatics of protein modules, Co-adviser with Dr. Michael Recce
2002-2004. Nick Navin 2002-2003, now a researcher at MD Anderson Cancer Center, Texas
Christian Gaffney, M.D. degree awarded from Harvard Medical School in 2011 - trained in the
Sudol laboratory in 2006 and 2009-2012, now a resident in Orthopedics Department at the
Medical Center in Salt Lake City, Utah.

Victor Tapia, Ph.D. student at Dr. Rudolf Volkmer laboratory at Charite in Berlin, Germany. I
serve as a thesis co-adviser of Mr. Tapia since 2007
Eline Remue, Ph.D. student at the University of Ghent, Belgium, I served as thesis co-adviser
with Dr. Jan Gettemans and Joel Vandekerckhove from 2009 to 2011.
Jessica Leigh Bennett, Ph.D. student at the University of Maryland, I serve as a co-adviser of
the student with Dr. Tony Passaniti since 2009 to the present.
Philip Kruber, University of Muenster, Germany, visiting researcher, Master of Science
student, March-June, 2012.
Postdoctoral Fellows and Research Scientists:
Julia Smith (M.D./Ph.D. Cornell University) 1987-1988. – Now a practicing physician and
faculty at New York University Medical School.
Ashok Srivastava - (Ph.D. University of Montreal, 1981) 1993-1994. – Now a faculty member
at the University of Montreal, Canada).
Sahng-June Kwak - (Ph.D. University of Seoul, Korea, 1986) 1993-1996. Now a Professor at
the Dankook University, Anseodong, Korea.
Cecile Bougeret - (Ph.D. Institut Cochin, Paris, France, 1995) 1995-1997. – Now a researcher
in the Avraham Lab at Harvard.
Xavier Espanel - (Ph.D. Ecole Normale Superieure de Lyon, France, 1997) 1997- 2000. –
Now a group leader at Pharmaceutical Co., Dijon, France.
Christian Schoeberl - (Ph.D. University of Munster, Munster, Germany, 1998) 1998. – Now a
researcher at a chemical company, Munich, Germany
Tony Korosi - (M.D. University of Pittsburgh, 1994) 1998-2000. – Now a practicing physician
at the White Plains Hospital, New York.
Makato Nagai (MD/Ph.D 2001 University and Medical School of Sapporo, Sapporo, Japan)
2001-2003 - Now a practicing M.D. at the Sapporo Hospital.
Akihiko Komuro (Ph.D. 1999, University of Showa, Tokyo, Japan) 2001-2003- Now an
Assistant Professor at The Tokyo Medical and Dental University;
Sylvie Ramboz (Ph.D. University of Strassbourg, 1995), 2000-2003
Tsutomu Oka (Ph.D. University of Tokyo, 2004), in the Sudol Lab from 2005 to 2010 - now a
member of the Qiagen Company, Tokyo, Japan
Yujin Inayoshi (Ph.D. University of Nagoya, 2005), in the Sudol Lab from 2005 to 2007- now a
researcher at the University of Nagoya, Iijima Lab
Heather King, M.D., 2007, three month long research in cancer signaling – last information
available: a resident in the Surgery Department at Geisinger Clinic.
Radhika Gogoi, (MD, PhD Hahnemann University, Philadelphia 1996; University of Colorado,
Denver, 2005), 2010 to present. Dr. Radhika Gogoi and Dr. John Nash of OBGYN at
Geisinger are close collaborators with the Sudol Lab on an endometrial cancer project.
Teaching Record:
*1987-1995, Signal Transduction lectures for Ph.D. and MD/Ph.D. students at the Rockefeller
University and Cornell University Medical College.
*1992-1993, Virology Course for Ph.D. students at The Rockefeller University, Co-organizers:
Hanafusa, H. and Sudol, M.
*1996 -1997, Journal Club for Ph.D. students at the Mount Sinai School of Medicine
*1997 -1998, Biochemistry discussion groups for MD students at Mount Sinai

*1997-1999, Lectures in Signal Transduction course at Mount Sinai (R. Iyengar; organizer)
*1999-2000 Mini-Medical School at the Mount Sinai School of Medicine, Selection Committee
2004-Seminar at Bucknell University, Lewisburg, PA, October 20 th , 2004, Host: Dr. Mitch
Chernin.
2007-Lecture at Susquehanna University, Selinsgrove, PA, February 20 th , 2007. Course
organizer: Dr. Tom Peeler
2008-Lecture at Susquehanna University, Selinsgrove, PA, March 25th, 2008. Course
organizer: Dr. Tom Peeler
2009-Lecture at Susquehanna University, Selinsgrove, PA, April 14th, 2009. Course
organizer: Dr. Tom Peeler.
External Thesis Committee/External Examiner:
2000 Caterina Venturelli, The University of Mexico, Mexico City
2004 Xun Shang, University of Singapore
2005 Marita Hiipakka, University of Tampere, Finland
2005 Teemu Juntilla, University of Turku, Finland
2009 Catherine Pan, National University of Singapore, Republic of Singapore
2009-present Jessica L. Bennett-Brusgard, University of Maryland, Baltimore, MD.
2010 Eline Remue, Gent University, Belgium;
2012 Bart Maslikowski, McMaster University, Hamilton, Canada
2013 Leszek Kotula, University of Wroclaw, Poland
Internal Committees:
Seminar Committee - Biochemistry Department, Mt Sinai School of Medicine: 1996-1998
Space Committee at the Biochemistry Department, Mt Sinai School of Medicine: 1999
Selection Committee for Mini-Medical School, Mt Sinai School of Medicine: 1999
Medicine Department, Mt Sinai School of Medicine, Seminar Series Committee: 2002-2004
Resident Research Day Judge: Geisinger Clinic: 2007 and 2008
Mini Sabaticals: Awards of Foreign Fellowships:
1992 Visiting Professor Fellowship awarded by the Ministry of Education of Japan for
collaborative work on the YRK proto-oncogene. (Three month stay). University of Tokyo,
Tokyo, Japan, Institute of Medical Sciences, Laboratory of Professor Tadashi Yamamoto.
1993 Visiting Scientist Fellowship awarded by the French League Against Cancer for
collaborative work on the signaling role of YES proto-oncogene in hematopoietic cells. (One
month stay). Institut Cochin of Molecular Biology, Paris, France, Laboratory of Professor
Siegmund Fischer.
1994 The Henri de Rothschild’s Fellowship for Outstanding Scientists to Visit French
Laboratories. Institut Curie, Orsay, France, Laboratory of Professor George Calothy. (Four

month award). The title of the proposed project: “Generation of Chromosubstrate for Tyrosine
Kinases”.
2000 EMBO Visiting Researcher Fellowship for collaborative work on the WW domain in
yeast and for updating the WW page on the world wide web. (One month stay). EMBL,
Heidelberg, Germany, Laboratories of Peer Bork and Matti Saraste.
Organization of Meetings & Consortia: Co-organizer of Research Symposia
on:
RETROVIRUSES, ONCOGENES AND GROWTH CONTROL held at The Rockefeller
University in New York on December 1, 1989. Speakers included: David Baltimore, Thomas
Benjamin, Michael Bishop, Raymond Erikson, Dennis Stacey, Howard Temin and Peter K.
Vogt.
ONCOGENES AND CELL SIGNALING held at The Rockefeller University in New York on
May 7, 1997. Speakers included: Joan Brugge, Harold Varmus, Robert Weinberg, Peter K.
Vogt, Tom Parsons, Steve Martin, and Raymond Erikson.
25th ANNIVERSARY OF THE DISCOVERY OF c-SRC GENE; ROLE OF TYROSINE
PHOSPHORYLATION IN SIGNALING. Held at the Osaka Bioscience Institute, Osaka,
Japan, May 10-12, 2000, Speakers: Oncogene Researchers from USA and Japan.
SEEFELD CONVENTION, Consortium on the nomenclature to describe protein domains and
their cognate motifs. Satellite Symposium in Seefeld, Austria in connection with the meeting
on “Functional Protein Modules”, October 6-10, 2001. (The convention was published in
FEBS. Lett, 513, 141-144)
: .
PROTEIN MODULES CONSORTIUM, Leaders: Bruce Mayer (University of Connecticut,
USA), Tony Pawson (University of Toronto, Canada); Giulio Superti-Furga (Center for
Molecular Medicine, Austria) and Marius Sudol (Geisinger, USA). An international association
focused on the promotion of scientific knowledge concerning the structure and function of
protein modules. The PMC – Protein Modules Consortium web page address is:
(www.proteinmodules.org).
FEBS WORKSHOP ON PLASTICITY OF MODULAR PROTEIN DOMAINS held in Seefeld,
Austria from September 10-15, 2005; Organizers: Mario Gimona (University of Salzburg,
Austria); Marius Sudol (Geisinger, USA).
FEBS WORKSHOP ON SYNTHETIC BIOLOGY OF MODULAR PROTEIN DOMAINS held in
Seefeld, Austria from September 8-13, 2007; Organizers: Mario Gimona (University of
Salzburg, Austria) and Marius Sudol (Geisinger, USA).
SIGNALING BY G PROTEIN LINKED RECEPTORS: FROM BENCH TO CLINIC held at the
Center for Health Research, Danville, September 21, 2007. Speakers included: Allen Spiegel,
Terry Kenakin, Alan Smrcka, Olivier Civelli, Craig Malbon, Lakshmi Devi (Organizers: Janet
Robishaw, Gerda Breitwieser, Cathy Beinlich, David Carey and Marius Sudol).
FIRST WORKSHOP ON THE NEWLY EMERGING TUMOR SUPPRESSOR PATHWAY
KNOWN AS THE HIPPO PATHWAY, held in Rome, Italy, April 22 and 23, 2009. Organizers:

Giovanni Blandino (Regina Elena Cancer Center, Italy), Yossi Shaul (Weizmann Institute,
Israel), Marius Sudol (Geisinger, USA) and Michael Yaffe (MIT, USA).
FEBS WORKSHOP ON MODULAR PROTEIN DOMAINS IN HEALTH AND DISEASE held in
Seefeld, Austria from September 5-10, 2009; Organizers: Stephan Feller (University of
Oxford, UK), Mario Gimona (University of Salzburg, Austria); Marius Sudol (Geisinger, USA).
SECOND WORKSHOP ON THE TUMOR SUPPRESSOR HIPPO PATHWAY, held in Rome
(Ariccia), Italy, November 2-5, 2010. Organizers: Giovanni Blandino (Regina Elena Cancer
Center, Italy), Georg Halder (University of Texas, USA), Helen McNeill (University of Toronto,
Canada), Yossi Shaul (Weizmann Institute, Israel), Sabrina Strano (Regina Elena Cancer
Center, Italy), Marius Sudol (Geisinger, USA) and Michael Yaffe (MIT, USA).
FEBS WORKSHOP ON “PROTEIN MODULES AND NETWORKS IN HEALTH AND
DISEASE” to be held in Seefeld, Austria from September 14-18, 2011; Organizers: Giulio
Superti-Furga (Center for Molecular Medicine, Austria), Anne-Claude Gavin (EMBL, Germany)
and Marius Sudol (Geisinger, USA).
KEYSTONE SYMPOSIA ON “THE HIPPO TUMOR SUPPRESSOR NETWORK; FROM
ORGAN SIZE CONTROL TO STEM CELLS AND CANCER”. May 19-23, 2013, Hyatt
Regency Hotel, Monterey, California. Organizers: Principal Organizer: Marius Sudol
(Geisinger, USA). Co-organizers: Helen McNeill (University of Toronto, Canada), Georg
Halder (University of Texas, USA) and Giovanni Blandino (Regina Elena Cancer Center,
Italy).
FEBS WORKSHOP ON “PROTEIN MODULES FOR SYSTEMS ENGNEERING AND
THERAPEUTIC INNOVATION” to be held in Seefeld, Austria, September, 2015; Organizers:
Giulio Superti-Furga (Center for Molecular Medicine, Austria), Wendell Lim (Stanford
University, USA), Marius Sudol (Geisinger, USA) and Michael Yaffe (MIT, USA).
Publications (peer-reviewed review articles are also included):
1. Patlewicz, S., and Sudol, M. (1976) “Wachsen und Bauen, Konstructionen in Natur
und Technik” ed. Otto Patzelt, Universe, 12, 320. [review].
2. Sudol, M. (1978) Peptides as Cell Growth Regulators. Rev. Cell Biol. 4, 325-340
[review].
3. Klein, A., Branny, J., Sudol, M., Knycz, M., Drozd, C., and Szuro, A. (1979) The
Influence of Non-dialysable Peptide Fraction from Bovine Blood Plasma on the Amino Acid
Incorporation in BHK-21 Normal and RSV Transformed Cells. Folia Histochem. Cytochem.,
17, 353-365.
4. Sudol, M., (1982) A Piece of Knowledge. Mol. Cell. Biochem., 49, 62.
5. Nagamine, Y., Sudol, M., and Reich, E., (1983) Hormonal Regulation of Plasminogen
Activator mRNA Production in Porcine Kidney Cell Line. Cell, 32, 1181-1190.
6. Schleuning, W-D., Sudol, M., and Reich, E., (1983) A Proenzyme from Chicken
Plasma Related to Plasminogen Activator and Kallikrein. J. Biol. Chem., 258, 14106-14115.
7. Sudol, M. (1983) Hormonal Regulation of Plasminogen Activator Production in Porcine
Kidney Cell Line. Ph.D. Thesis, The Rockefeller University (1985 Publication of UMI, #85-111-
30)
8. Sudol, M., and Reich, E. (1984) Purification and Characterization of Plasminogen
Activator from Kidney Cells. Biochem. J., 219, 917-978.
9. Sudol, M. (1985) Hormonal Regulation of Protein Synthesis in Cultured Kidney Cells.

Mol. Cell. Endocr., 40, 245-255.
10. Sudol, M., Lerner, T.L., and Hanafusa, H. (1986) Polymerase-Defective Mutant of the
Bryan High-Titer Strain of Rous Sarcoma Virus. Nucleic Acid Res., 14, 2391-2405.
11. Sudol, M., and Hanafusa, H. (1986) Cellular Proteins Homologous to the Viral yes
Gene Product. Mol. Cell. Biol., 6, 2839-2846.
12. Kornbluth, S., Sudol, M., and Hanafusa, H. (1987) Association of the Polymavirus
Middle T Antigen with c-yes Protein. Nature, 325, 171-173.
13. Sudol, M., Alvarez-Buylla, A., and Hanafusa, H. (1988) Differential Developmental
Expression of Cellular yes and src Proteins in Cerebellum. Oncogene Res., 2, 345-355.
14. Sudol, M., Kieswetter, C., Zhao, Y-H., Dorai, T., Wang, L-H., and Hanafusa, H. (1988)
Nucleotide Sequence of a cDNA for the Chick yes Proto-oncogene: Comparison with the Viral
yes Gene. Nucleic Acid Res., 16, 9876.
15. Sudol, M. (1988) Expression of Proto-oncogenes in Neural Tissues. Brain Research
Reviews, 13, 391-403 [review]
16. Sudol, M., Kuo, F., Shigemitsu, L., and Alvarez-Buylla, A. (1989) Expression of the yes
Proto-oncogene in Cerebellar Purkinje Cells. Mol. Cell. Biol., 9, 4545-4549.
17. Sudol, M. (1989) Functional Expression of the yes Proto-oncogene Protein in Xenopus
Oocytes Injected with Chicken Cerebellar mRNA. J. Neurosci. Res., 24, 1-8.
18. Sudol, M. (1990) Physiological Functions of the yes Proto-oncogene. Exp. Med., 8, 94-
100 [review]
19. Zhao, Y-H., Krueger, J., and Sudol, M. (1990) Expression of Cellular-yes Protein in
Mammalian Tissues. Oncogene 5, 1629-1635.
20. Lustig, R., Sudol, M., Pfaff, D.W., and Federoff, H.J. (1991) Estrogenic Regulation and
Sex Dimorphism of Growth-Associated Protein 43 kDa (GAP-43) Messenger RNA in the Rat.
Mol. Brain Res. 11, 125-132.
21. Grandori, C., Sudol, M., and Hanafusa, H. (1991) c-yes Protein Kinase is Associated
with a 38 kD Protein in Cerebellum. Oncogene 6, 1063-1066.
22. Krueger, J., Zhao, Y-H, Murphy, D., and Sudol, M. (1991) Differential Expression of
p62c-yes Proto-Oncogene in Normal, Hyperplastic, and Neoplastic Human Epidermis.
Oncogene 6, 933-940.
23. Zhao, Y-H., Baker, H., Walaas, I.S., and Sudol, M. (1991) Localization of the yes
Protein in Discrete Regions of Mammalian Brain. Oncogene. 6, 1725-1733.
24. Zhao, Y-H., Sudol, M., Hanafusa, H., and Kruger, J. (1992) Increased Tyrosine Kinase
Activity of Src During Calcium-induced Keratinocyte Differentiation. Proc. Natl. Acad. Sci.
USA. 89, 8298-8302.
25. Sudol, M. (1993) Nonreceptor Protein Tyrosine Kinases. In: “The Molecular Basis of
Human Cancer” (Eds. B.G. Neel & R. Kumar), Futura Publishing Co., New York. pp. 203-224
[review].
26. Sudol, M. Grant, S.G.N., and Maisonpierre, P. (1993) Proto-oncogenes and Signaling
Processes in Neural Tissues. Neurochemistry International 22, 369-384 [review].
27. Walaas, I.S., Zhao, Y-H., and Sudol, M. (1993) Neuronal Localization of the Tyrosine-
Specific Protein Kinase p62c-yes in Rat Basal Ganglia. Neurochem. Res. 18, 43-46.
28. Sudol, M., Greulich, H., Newman, L., Sarkar, A., Sukegawa, J., and Yamamoto, T.
(1993) A Novel Yes-Related Kinase, Yrk, is Expressed at Elevated Levels in Neural and
Hematopoietic Tissues. Oncogene. 8, 823-831.
29. Silverman, L., Sudol, M. and Resh, M.D. (1993) Members of the Src Family of Nonreceptor
Tyrosine Protein Kinases Share a Common Mechanism for Membrane Binding. Cell
Growth & Differentiation. 4, 475-482.
30. Loganzo, F., Dosik, J.S., Zhao, Y., Vidal, M.J., Nanus, D.M., Sudol, M., and Albino,
A.P. (1993) Elevated Expression of Protein Tyrosine Kinase c-Yes, But Not c-Src, in Human
Malignant Melanoma. Oncogene. 8, 2637-2644.

31. Sargiacomo, M., Sudol, M., Tang, Z-L., and Lisanti, M. (1993) Signal Transducing
Molecules and GPI-linked Proteins Form a Caveolin-rich Insoluble Complex in MDCK cells. J.
Cell Biol. 122, 789-807.
32. Zhao, Y-H., Uyttendaele, H., Krueger, J., Sudol, M., and Hanafusa, H. (1993)
Inactivation of c-Yes Tyrosine Kinase by Elevation of Intracellular Calcium Levels. Mol. Cell.
Biol. 13, 7507-7514.
33. Fang, K.S., Barker, K., Sudol, M., and Hanafusa, H. (1994) A Transmembrane Proteintyrosine
Phosphatase Contains Spectrin-like Repeats in its Extracellular Domain. J. Biol.
Chem. 269,14056-14063.
34. Sudol, M. (1994) Yes-Associated Protein (YAP65) is a Proline-Rich Phosphoprotein
that Binds to the SH3 Domain of the Yes Proto-oncogene Product. Oncogene 9, 2145-2152.
35. Bork, P., and Sudol, M. (1994) The WW Domain: A New Signaling Site in Dystrophin?
Trends in Biochem. Sci. 19, 531-533.
36. Sudol, M., Bork, P., Einbond, A., Kastury, K., Druck, T., Negrini, M., Huebner, K., and
Lehman, D. (1995) Characterization of the Mammalian YAP (Yes-associated Protein) Gene
and Its Role in Defining a Novel Protein Module, the WW Domain. J. Biol. Chem. 270, 14733-
14741.
37. Chen H.I., and Sudol, M. (1995) The WW Domain of Yes-Associated Protein Binds a
Novel Proline-Rich Ligand that Differs from the Consensus Established for SH3-Binding
Modules. Proc. Natl. Acad. Sci. USA. 92, 7819-7823.
38. Sudol, M., Chen, H.I., Bougeret, C., Einbond, A., and Bork, P. (1995) Characterization
of a Novel Protein Binding Module - the WW Domain. FEBS Lett. 369, 67-71.
39. Kim, J.I., Suk, K., Shim, E.H., Kim, S.H., Jang, J.J., Price, K., Sudol, M., and Seo, J.S.
(1995) Tumors Induced by Deregulated Expression of SH2 and SH3 Domains of Chicken c-
Yes in Transgenic Mice. Mol. and Cells. 5, 641-644.
40. Chen, H.I., and Sudol, M. (1996) Identification and Characterization of Protein Ligands
to the WW Domain by Western Blotting. Techniques in Prot. Chemistry, 7, 3-12.
41. Einbond, A., and Sudol, M. (1996) Towards Prediction of Cognate Complexes
Between the WW Domain and Proline-Rich Ligands. FEBS Lett. 84, 1-8.
42. Garnier, L., Wills, J., Verderame, M.F., and Sudol, M. (1996) WW Domains and
Retrovirus Budding. Nature, 381, 744-745.
43. Sudol, M. (1996) The WW Module Competes with the SH3 Domain? Trends in
Biochem. Sci. 21, 162-163.
44. Sudol, M. (1996) The WW Domain Binds Polyprolines and is Involved in Human
Diseases. Exp. and Mol. Med. 28, 65-69.
45. Macias, M.J., Hyvonen, M., Baraldi, E., Schultz, J., Sudol, M., Saraste, M., and
Oschkinat, H. (1996) The Structure of the WW Domain in Complex with a Proline-rich Peptide.
Nature, 382, 646-649.
46. Sudol, M. (1996) Structure and Function of the WW Domain. Prog. in Biophys. and
Mol. Biol. 65, 113-132.
47. Ermekova, K., Chang, A., Zambrano, N., Candia, P.D., Russo, T., and Sudol, M.
(1997) Protein Implicated in Alzheimer Disease: The Role of FE65, a New Adaptor that Binds
Beta-Amyloid Precursor Protein. “Molecular and Cellular Mechanisms of Neuronal Plasticity”
Ed. Ehrlich, Y., Plenum Press, New York, London, Boston pages: 161-180 [review].
48. Zambrano, N., Buxbaum, J.D., Minopoli, G., Fiore, F., de Candia, P., de Renzis, S.,
Faraonio, R., Sabo, S., Cheetham, J., Sudol, M., and Russo, T. (1997) Interaction of the
Tandem PID/PTB-related Domain of FE65 with Wild Type and Mutant Alzheimer’s Beta
Amyloid Precursor Protein. J. Biol. Chem. 271, 6399-6405
49. Linn, H., Ermekova, K., Rentschler, S., Sparks, A., Kay, B., and Sudol, M. (1997)
Using Molecular Repertoires to Identify High-Affinity Peptide Ligands of the WW Domain of
Human and Mouse YAP. Biol. Chem. 378, 531-537

50. Chen, H.I., Einbond, A., Kwak, S.J., Linn, H., Koepf, E., Peterson, S., Kelly, J. and
Sudol, M. (1997) Characterization of the WW Domain of Human Yes-Associated Protein and
Its Polyproline-containing Ligands. J. Biol. Chem. 272, 17070-17077
51. Gavva, N.R., Gavva, R., Ermekova, K., Sudol, M., and Shen, C.K.J. (1997) Interaction
of WW Domains with Hematopoietic Transcription Factor p45/NF-E2 and RNA Polymerase II.
J. Biol. Chem. 272, 24105-24108
52. Sudol, M. (1997) The WW Domain and its Proline-rich Ligand in Alzheimer’s disease
and Muscular Dystrophy. Emerging Therapeutic Targets 1, 81-84
53. Ermekova, K.S., Zambrano, N., Linn, H., Minopoli, G., Gertler, F., Russo, T., and
Sudol, M. (1997) The WW Domain of Neural Protein FE65 Interacts with Proline-rich Motifs in
Mena, the Mammalian Homolog of Drosophila Enabled. J. Biol. Chem. 272, 32869-32878
54. Marchetti, D., Parikh, N., Sudol, M., and Gallik, G.E (1998) Stimulation of the Protein
Tyrosine Kinase c-Yes but not c-Src by Neurotrophins in Human Brain-Metastatic Melanoma
Cells. Oncogene 16, 3253-60.
55. Sudol, M. (1998) From Src Homology Modules to Other Signaling Domains: Proposal
of the ‘Protein Recognition Code’. Oncogene 17, 1469-1474
56. Harty, R.N., Paragas, J., Sudol, M. and Palese, P. (1999) A Proline-rich Motif Within
the Matrix Protein of VSV and Rabies Virus Interacts with WW-domains of Cellular Proteins:
Implications for Viral Budding. J. Virol. 73, 2921-2929
57. Rentschler, S., Linn, H., Deininger, K., Bedford, M.T., Espanel, X., and Sudol, M. (1999)
The WW Domain of Dystrophin Requires EF-hands Region to Interact with Beta-dystroglycan.
Biol. Chem. 380, 431-442.
58. Koepf, E.K., Petrassi, H.M., Sudol, M., and Kelly, J.W. (1999) WW: An Isolated Threestranded
Anti-parallel Beta-sheet Domain That Unfolds and Refolds Reversibly; Evidence for
a Structured Hydrophobic Cluster in Urea and GdnHCl and a Disordered Thermal Unfolded
State. Protein Science 8, 841-853.
59. Espanel, X., and Sudol, M. (1999) A Single Point Mutation in a Group I WW Domain
Shifts Its Specificity to That of Group II WW Domains. J. Biol. Chem. 274, 17284-17289
60. Luton, F., Verges, M., Vaerman, J.P., Sudol, M., and Mostov, K.E. (1999) The Src
Family Protein Tyrosine Kinase p62YES Controls IgA Transcytosis in vivo. Mol. Cell. 4, 627-
632.
61. Mohler, P., Donaldson, S., Kerda, S., Boacher, R. Sudol, M., Stutts, J., and Milgram, S,L.
(1999) Yes-associated Protein 65 Localizes p62c-yes to the Apical Compartment of Airway
Epithelium by Association with EBP50. J. Cell. Biol. 147, 879-890.
62. Koepf, E.K., Petrassi, M.H., Ratnaswamy, G., Huff, M.E., Sudol, M., and Kelly, J.W.
(1999) Characterization of the Structure and Function of W-F WW Domain Variants:
Identification of a Natively Unfolded Protein that Folds Upon Ligand Binding. Biochemistry, 38,
14338-14351.
63. Kay, B.K., Williamson, M.P., and Sudol, M. (2000) The Importance of Being Proline: The
Interaction of Proline-rich Motifs in Signalling Proteins with their Cognate Domains. FASEB, J.
14, 231-241.
64. Martins-Green, M., Bixby, J.L., Yamamoto, T., Graf, T., and Sudol, M. (2000) Tissue
Specific-Expression of Yrk Kinase: Implications for Differentiation and Inflammation. Int. J.
Biochem. & Cell Biol. 32, 351-364.
65. Summy, J.M., Guappone, A.C., Sudol, M. and Flynn, D.C. (2000) The SH3 and SH2
Domains are Capable of Directing Signaling Specificity Between the Non-receptor Tyrosine
Kinases: c-Src and c-Yes. Oncogene, 19, 155-160
66. James, M., Ottersbach, K., Ilsley, J.L., Sudol, M., and Winder, S. (2000) Phosphorylation
of Beta-dystroglycan on Tyrosine Regulates Its Binding to the Carboxy-terminus of Utrophin.
J. Cell. Sci. 113,1717-1726
67. Vignano, A.T., Zenzo, G., Sudol, M., Cesareni, G., and Dente, L. (2000) Contribution of

Different Modules in the Utrophin Carboxy-terminal Region to the Formation and Regulation of
the DAP Complex. FEBS Lett. 471, 229-234.
68. Zhang, Y.Z., Lindblom, T., Carnahan, R., Chang, A., Gould, K., Sudol, M., Sluder, A.,
and Golemis, E. (2000) Dim1 Regulation of mRNA Splicing is Required for Cell Cycle
Progression. Gene, 257, 33-43
69. Sotgia, F., Das, K., Bedford, M., Petrucci, T.C., Macioce, P., Minetti, C., Sudol, M., and
Lisanti, P. (2000) Caveolin-3 Directly Interacts with the C-terminal Tail of Beta-dystroglycan.
Identification of a Central WW-like Domain Within Caveolin Family Members. J. Biol. Chem.
275, 38048-38058.
70. Huang, X., Roy, F., Zhang, R., Joachimiak, A., Sudol, M., and Eck, M.J. (2000)
Recognition of a Proline Motif in Beta-dystroglycan by an "Embedded" WW Domain in Human
Dystrophin. Nature Struct. Biol. 7, 634-638.
71. Sudol, M., and Hunter, T. (2000) NeW Wrinkles for an Old Domain. Cell 103, 1001-1004
[review].
72. Chang, A., Cheang, S., Espanel, X., and Sudol, M (2000) Rsp5 WW Domains Interact
Directly with the Carboxy-terminal Domain of RNA Polymerase II. J. Biol. Chem., 275, 20562-
20571.
73. Sudol, M., Bork, P., and Chen, H. (2000) SH3 Kinase Domain-associated Protein, a
Signaling Domain Therein, Nucleic Acids Encoding the Protein and the Domain, and
Diagnostic and Therapeutic Uses Thereof. United States Patent, Number 6,022,7240.
74. Sudol, M., Sliwa, K., and Russo, T. (2001) Functions of WW Domain in Nucleus. FEBS
Lett., 490, 190-195.
75. Strano, S., Munarriz, E., Rossi, M., Cristofanelli, B., Castagnolo, L., Shaul, Y., Sacchi, A.,
Oren, M., Sudol, M., Cesareni, G., and Blandino, G. (2001) Physical Interaction with Yesassociated
Protein (YAP) Enhances p73 Transcriptional Activity. J. Biol. Chem., 276, 15164-
73.
76. Espanel, X and Sudol, M. (2001) Yes-associated Protein and p53-binding Protein-2
Interact Through Their WW and SH3 domains. J. Biol. Chem., 276, 14514-23.
77. Ilsey, J.L., Sudol, M., and Winder S.J. (2001) The Interaction of Dystrophin with Betadystroglycan
is Regulated by Tyrosine Phosphorylation. Cell Signalling, 13, 652-632.
78. Zambrano, N., Bruni, P., Minopoli, G., Mosca, R., Molino, D., Russo, C., Schettini, G.,
Sudol, M., and Russo, T. (2001) The Beta-amyloid Precursor Protein APP is Tyrosine
Phosphorylated in Cells Expressing a Constitutively Active Form of the Abl Proto-oncogene.
J. Biol. Chem., 276, 19787-19792.
79. Okazawa, H., Sudol, M., and Rich, T. (2001) PQBP-1(NP/PQ): A Polyglutamine Tractbinding
Protein and Nuclear Inclusion-forming Protein. Brain Research, 56, 273-280.
80. Sotgia, F., Lee, H., Bedford, M., Petrucci, T., Sudol, M., and Lisanti, P. M. (2001) Tyrosine
Phosphorylation of Beta-dystroglycan at its Extreme C-terminal PPxY Motif Recruits SH2
Domain Containing Proteins. Biochemistry, 40, 14585-92.
81. Wu, X., Chang, A., Sudol, M., and Hanes, S.D. (2001) Genetic Interaction Between
ESS1 Prolyl-isomerase and the RSP5 Ubiquitin Ligase Reveal Opposing Effects on RNA
Polymerase II Function. Current Genetics 40, 234-242
82. Sudol, M. (2002) WW Domains, Wiley Encyclopedia of Molecular Medicine, John Wiley &
Sons, Inc. New York,,Volume 5, pages 3405-3408.
83. Ilsey, J.L., Sudol, M., and Winder S.J. (2002) The WW Domain: Linking Cell Signalling to
the Membrane Cytoskeleton. Cell Signalling, 14, 183-189
84. Aasland, R., Abrams, C., Ampe, C., Ball, L., Bedford, M., Cesarenni, G., Gimona, M.,
Hurley, J., Jarchau, T., Lehto, V-P., Lemmon, M., Lindling, R., Mayer, B., Nagai, M., Sudol,
M., Walter, U., and Winder, S. (2002) Normalization of Nomenclature for Peptide Motifs as
Ligands of Modular Protein Domains. FEBS. Lett, 513, 141-144
85. Macias, M., Wiesner, S., and Sudol, M. (2002) WW and SH3 domains: Two Scaffolds for

Proline-rich Ligands. FEBS Lett. 513, 30-37.
86. Okazawa, H., Rich, T., Chang, A., Lin, X., Waragi, M., Kajikawa, M., Shibata, M.,
Enokido, Y., Hatanaka, H., Mouradian, M., Sudol, M., and Kanazawa, I. (2002) Interaction
Between Mutant Ataxin-1 and PQBP-1 Affects Transcription and Cell Death. Neuron, 34, 701-
713
87. Summy, J.M., Sudol, M., Eck, M., Monteiro, N.A., Gatesman, A., and Flynn D.C. (2003)
Specificity in Signaling by c-Yes. Frontiers in Biosci., 8, 185-205
88. Sotgia, F., Bonuccelli, G., Bedford, M., Brancaccio, A., Wilson, M., Campos-Gonzales,
R., Brooks, J., Sudol, M., and Lisanti M.P. (2003) Ligand-induced Phosphorylation of Betadystroglycan
on Tyrosine 892. Biochemistry 42, 7110-7123.
89. Basu, S., Totty, N.F., Irwin, MS., Sudol, M., and Downward, J. (2003) Akt Phosphorylates
the Yes-Associated Protein YAP to Induce Interaction with 14-3-3 and Attenuation of p73-
Mediated Apoptosis. Mol. Cell 11, 11-23.
90. Komuro, A., Nagai, M. Navin, N. and Sudol, M. (2003) WW Domain-containing Protein
YAP Associates with ErbB-4 and Acts as a Co-transcriptional Activator for the Carboxyterminal
Fragment of ErbB4 that Translocates to the Nucleus. J. Biol Chem. 278, 33334-
33341
91. Espanel, X., Navin, N., Kato, Y., Tanokura, M., and Sudol, M. (2004) Probing WW
Domains to Uncover and Refine Determinants of Specificity in Ligand Recognition.
Cytotechnology 43,105-111.
94. Hu, H., Columbus, J., Zhang, Y., Wu, D., Lian, L., Carter, M., Davis, R., Sudol, M.
Rodwell, J., and Herrero, J. (2004) A Map of WW Domain Family Interactions. Proteomics, 4,
643-655
92. Bedford, M. and Sudol, M. (2004) SH3 and WW domains. Chapter in “Proteomics and
Protein-Protein Interactions” (Ed. Waksman, G.) Kluwer Academic Plenum Publishers.
93. Sudol, M. (2004) WW Domain in “Modular Protein Domains” (Eds. Cesareni, G., Gimona,
M., Sudol, M. and Yaffe, M.) Wiley VCH, Verlag Gmbh & Co. pages 59-72.
94. Hu, H., Columbus, J., Zhang, Y., Wu, D., Lian, L., Carter, M., Davis, R., Sudol, M.
Rodwell, J., and Herrero, J. (2004) A Map of WW Domain Family Interactions. Proteomics, 4,
643-655
95. Kato, Y., Nagata, K, Takahashi, M., Lian, L., Herrero, H., Sudol, M., and Tanokura M.
(2004) Common Mechanism of Ligand Recognition by Group-II/III WW Domains–Redefining
their Functional Classification. J. Biol. Chem. 279, 31833-31841.
96. Clump, D.A., Qazi, I., Sudol, M., and Flynn, D.C. (2005) Cellular-Yes Response to
Growth Factors Activation, Growth Factors, 23, 263-272.
97. Aqeilan, R.I., Donati, V., Palamarchuk, A., Kaou, M., Trapasso, F., Pekarsky, Y., Sudol,
M. and Croce, M.C. (2005) WW Domain-containing Proteins, WWOX and YAP Compete for
Interaction with ErbB-4 and Modulate Its Transcriptional Function. Cancer Res., 65, 6764-
6772.
98. Sudol, M., Abraczinskas, J., Humbert, J., and Farooq, A. (2005) WW or WoW: The WW
Domains in a Permanent Union of Bliss. IUBMB Life, 57, 773-778 [review].
99. Hoshino, M. Qi, M. L., Yoshimura N., Miyashita, T., Tagawa, K., Wada, Y., Enokido, Y.,
Marubuchi, S., Harjes P., Arai, N., Oyanagi, N., Blandino, G., Sudol, M., Rich, T., Kanazawa,
I., Wanker, E.E., Saitoe, M., and Okazawa, H. (2006) Transcriptional Repression Induces a
Slowly Progressive Atypical Neuronal Death Associated with Changes of YAP Isoforms and
p73. J Cell Biol. 172, 589-604.
100. Farooq, A., Sudol, M. and Zhou, M.M. (2006) Two is Better Than One: Structure,
Function and Mechanism of Protein Domains Operating in Tandem Repeats. In “Focus on
Cellular Signalling Research”, Nova Science Publishers, Inc., Editor D.T. Leeds, pages 109-
129.

101. Masker, K., Golden, A., Gaffney, C., Mazack, V., Schwindinger, W., Zhang, W., Wang,
L-H, Carey, DJ., and Sudol, M. (2007) Transcriptional Profile of Rous Sarcoma Virus
Transformed Chicken Embryo Fibroblasts Reveals New Signaling Targets of Viral-src.
Virology, 364, 10-20.
102. Aqeilan, R.I., Donati, V., Gaudio, E., Nicoloso, M.S., Sundvall, M, Korhonen, A., Lundin,
J., Isola, J., Sudol, M., Joensuu, H., Croce, C., and Elenius, K. (2007) Clinical Significance of
WWOX-ErbB4 Association in Breast Cancer. Cancer Res., 67, 9330-9336
103. Kawahara, M., Hori, T., Oka, T., Sudol, M., and Uchiyama, T. (2008) Kpm-Lats2 is
Linked to Chemo-sensitivity of Leukemic Cells Through the Stabilization of p73. Blood, 112,
3856-3866.
104. Oka, T., Mazack, V., and Sudol, M. (2008) Mst2 and Lats Kinases Regulate Apoptotic
Function of YAP. J. Biol. Chem. 283, 27534-27546.
105. Oka, T., and Sudol, M. (2008) Duality of YAP: an Oncogene and the Promoter of
Apoptosis. Adaptor Proteins and Cancer. (ISBN-978-81-7895-344-1), Editor: M-M.
Georgescu, Transworld Research Network, pages 209-218.
106. Zagurovskaya, M. S., Shareef, M.M., Das, A., Reeves, A., Sudol, M., Bedford, M.T.,
Gundawar, J., Prichard, J., Mohiuddin, M., and Ahmed, M.M. (2009) EGR-1 Forms a Complex
with YAP-1 and Upregulates Bax Expression in Irradiated Prostate Carcinoma Cells. Accepted
for publication in Oncogene, 28, 1121-131.
107. Bertini, E., Oka, T., Sudol, M. Blandino, G., and Strano, S. (2009) YAP: At the
Crossroad Between Transformation and Tumor Suppression. Cell Cycle, 8, 49-57 (review).
108. Oka, T and Sudol, M (2009) Nuclear Localization and Pro-apoptotic Signaling of YAP2
Require Intact PDZ-binding Motif. Genes to Cells, 14, 607-615.
109. Li, X., Hyink, P., Radbill, B., Sudol, M., Zhang, H., and Wilson, P. (2009) siRNA
Analysis of Protein Kinase X (PRKX) Effects on Renal Epithelial Cells and Embryonic Mouse
Kidney Development. Kidney Int., 76, 54-62.
110. Blandino, G., Shaul, Y., Strano, S., Sudol, M., and Yaffe, M. (2009) The Hippo Tumor
Suppressor Pathway: A Brainstorming Workshop. Sci. Signal., 2, 1-4.
111. Lin, Q., Wang, J., Childress, C., Sudol, M. Carey, D.J., and Yang, W. (2010) HECT E3
Ubiquitin Ligase Nedd4-1 Ubiquitinates ACK and Regulates EGF-induced Degradation of
EGFR and ACK. Mol. Cell. Biol., 30, 1541-1554.
112. Ehsanian, R., Brown, M, Lu, H., Yang, X., Pattatheyil, A., Yan, B., Duggal, P., Chuang,
R., Feller, S., Sudol, M., Chen, Z., and Van Waes, C. (2010) YAP Dysregulation by
Phosphorylation or Delta-Np63-mediated Gene Repression Promotes Proliferation, Survival
and Migration in Head and Neck Cancer Subsets. Oncogene, 29, 6160-6171.
113. Tapia, V.E., Nicolaescu, E. McDonald, C.B., Musi, V., Oka, T., Inayoshi, Y., Satteson
A.C., Mazack, V., Humbert, J., Gaffney, J.C., Beullens, M., Schwartz, C.E., Landgraf, C.,
Volkmer, R., Pastore, A., Farooq, A., Bollen, M., and Sudol, M. (2010). The Y65C Missense
Mutation in the WW Domain of the Golabi-Ito-Hall Syndrome Protein PQBP1 Affects Its
Binding Activity and Deregulates Pre-mRNA Splicing. J. Biol. Chem. 285, 19391-19401.
114. Sudol, M., and Harvey, K. (2010) The Modularity in the Hippo Signaling Pathway. TiBS,
35, 627-633.
115. Oka, T., Remue, E., Meerschaert, K., Vanloo, B., Boucherie, C., Gfeller, D., Bader,
G.D., Sidhu, S., Vandekerckhove, J., Gettemans, J., Sudol, M. (2010) Functional Complex
Between YAP2 and ZO-2 is PDZ Domain Dependent, Regulates YAP2 Nuclear Localization
and Signaling. Biochemical J, 432, 461-72 (THIS ARTICLE WAS SELECTED BY FACULTY
BIOLOGY 1000 in 2011).
116. Remue, E., Meerschaert, M., Oka, T., Boucherie, C., Vandekerckhove, J., Sudol, M.,and
Gettemans, J. (2010) TAZ Interacts with Zonula Occludens-1 and -2 proteins in a PDZ-1
Dependent Manner. FEBS Lett., 584, 4175-4180.
117. Muramatsu,T., Imoto, I., Matsui, T., Kozaki, K., Haruki, S., Sudol, M., Shimada, Y.,

Kawano,T., Tsuda, H., and Inazawa, J. (2011) YAP is a Candidate Oncogene for Esophageal
Squamous-cell Carcinoma. Carcinogenesis, 32, 389-398.
118. Sudol, M. (2010) Newcomers to the WW Domain-mediated Network of the Hippo Tumor
Suppressor Pathway. Genes and Cancer, 1, 1115-1118.
119. McNeill, H., Blandino, G., Halder, G., Strano, S., Sudol, M., and Shaul, Y (2011) Second
Workshop on the Hippo Tumor Suppressor Pathway - Meeting Report, Cell Death &
Differentiation, 18, 1388-1390.
120. Sudol, M. (2011) From Rous Sarcoma Virus to Plasminogen Activator, Src Oncogene and
Cancer Management. Oncogene, 30, 3003-3010.
121. Oka, T., Schmitt, A.P., and Sudol, M. (2012) Opposing Roles of Angiomotin Like 1 and
Zona Occludens-2 on Pro-apoptotic Function of YAP. Oncogene, 31, 128-134.
122. McDonald, C., McIntosh, S., Mikles, D., Bhat, V., Deegan, B., Seldeen, K., Saeed, A.,
Buffa, L., Sudol, M., Nawaz, Z., Farooq, A. (2012) Biophysical Analysis of the Binding of WW
Domains of YAP2 Transcriptional Regulator to PPXY Motifs within WBP1 and WBP2 Adaptors.
Biochemistry, 50, 9616-9627.
123. Pan C,Q., Sudol, M., Sheetz, M., and Low, B.C. (2012) Modularity and Functional
Plasticity of Scaffold Proteins as P(l)acemakers in Cell Signaling. Cell Signaling, 24,2143-2165
124. McDonald CB, Buffa L, Bar-Mag T, Salah Z, Bhat V, Mikles DC, Deegan BJ, Seldeen KL,
Malhotra A, Sudol M, Aqeilan RI, Nawaz Z, Farooq A. (2012) Biophysical Basis of the Binding of
WWOX Tumor Suppressor to WBP1 and WBP2 Adaptors. J. Mol. Biol. 422, 58-74
125. Sudol, M., McDonald, C.B., and Farooq, A. (2012) Molecular Insights into the WW Domain
of the Golabi-Ito-Hall Syndrome Protein PQBP1. FEBS Letters, 586,2795-2799.
126. Sudol, M. Shields, D., and Farooq, A., (2012) Structures of YAP Protein Domains Reveal
Promising Targets for Development of New Cancer Drugs. Seminars in Cell & Dev Biol. 23,
827-833.
127. Sudol M, Cesareni G, Superti-Furga G, Just W. (2012) Special issue - Modular Protein
Domains. FEBS Letters, 586, 2571.
128. Fausti , F., Di Agostino, S., Cioce, M., Bielli, P., Sette, C., Pandolfi, P.P., Oren. M., Sudol.,
M., Strano, S., and Blandino., G. (2012) ATM-kinase Enables the Functional Axis of YAP, PML
and p53 to Promote Loss of Werner Protein- mediated Senescence. Mol Cell. Submitted.
129. Gaffney, C.J., Oka, T., Mazack, V., Hilman, D., Gat, U., Muramatsu, T., Inazawa, J.,
Golden, A., Carey, D.J., Farooq, A., Tromp, G., Sudol, M. (2012) Identification, Basic
Characterization and Evolutionary Analysis of Differentially Spliced mRNA Isoforms of Human
YAP1 Gene. Gene 509, 215-222.
130. Sudol, M. (2012) WW Domains in the Heart of Smad Signaling. Structure, 20, 1619-1620
131. Sudol, M. (2013) YAP and Its 8 Isoforms. Oncogene, accepted for publication.
132. Sudol, M., Gelman, H. I., and Zhang J. (2012) YAP1 Uses its Modular Protein Domains
and Conserved Sequence Motifs to Orchestrate Diverse Repertoires of Signaling, In: “The
Hippo Signaling pathway and Cancer”, Eds. Moshe Oren Yael Aylon. Publisher: Springer
Science, New York.
133. Strano, S., DiAgostino, S., Fausti, F., Sudol, M., and Blandino, G. (2013) PML Surfs into
Hippo Pathway. Special PML issue, Editors: P.P. Pandolfi and P. Pinton.
134. Bossuyt, W., Chen, C-L., Sudol, M., Pan, D.J., Kropp, A., and Halder, G. (2013)
Functional Differences in the Regulation of the Hippo Pathway Between Flies and Mice.
Oncogene, accepted for publication, January 23, 2013.
135. Iglesias-Bexiga, M., Cobos, E.S., Castillo, F., Oka, T., Mazack, V., Tapia, V.E., Landgraf,
C., Volkmer, R., Sudol, M., and Luque, I. (2013) Biophysical and Biochemical Analysis of the
Binding of WW domains of YAP Transcriptional Regulator to PPxY Motif Containing Peptides of
Patched and LAST Proteins. In preparation
136. Shao, X., Xing, X., Sudol, M. Deng, N., and Bader G.D. (2013) Predicting the Binding
Preference of WW Domains From Amino Acid Sequence. In preparation.

137. Nallet-Staub, F., Marsaud, V., Li, L., Gilbert, C., Dodier, S., Batallie, V., Sudol, M., Herlyn,
M., and Mauviel, A. (2013) Pro-Invasive Activity of the Hippo Pathway Effectors YAP and TAZ in
Cutaneous Melanoma. Cancer Res, submitted.
138. Abu-Ode, M., Tomer Bar-Mag, T., Kim, T.S., Salah , Z., Abdeen, S., Sudol, M., Sidhu, S.,
Kim, P.M., Aqeilan, R.I. (2013) Characterization of WW Domain Interactions of Tumor
Suppressor WWOX Reveals Its Association with Multi-protein Networks. Mol & Cell Proteomics.
Submitted
139. Yi, C., Shen, Z., Stemmer-Rachamimov, A., Dawany, N., Troutman, S., Showe, L.C., Liu,
Q., Giovannini, M., Shimono, A., Sudol, M., Holmgren, L., Stanger , B.Z., and Kissil, J.L. (2013)
Angiomotin-p130 is Required for Yap-mediated Hepatic Epithelial Cell Expansion and
Tumorigenesis. Submitted for publication to Science Signaling.
140. Campbell, K.N., Wong, J.S., Gupta, R., Asanuma, K., Sudol, M., He, J.C., and Mundel, P.
(2013) YAP Promotes Cell Survival by Inhibiting Pro-apoptotic Dendrin Signaling. Submitted to
JBC
Seminars and Lectures:
Summary of Invited Oral Presentations at International Meetings and
Workshops (1995-2009). All Presentations were on “The Role of the
WW Domain in Signaling and Disease”
Speaker at the Plenary Session of the Fifth International Conference on Protein Engineering,
Organizer: Dr. J. Geisow, March 1-4, 1996, Montpellier, France.
Lecture at the University of Lausanne, Switzerland, Hosted by the Director of the Institute of
Pharmacology: Dr. Bernard Rossier, March 7, 1996
Seminar at The European Institute of Oncology, Milan, Italy. March 12, 1996. Hosts (Directors):
Dr. Pier Giuseppe Pellicci and Dr. Pier Paolo Di Fiore.
Lecture at the Institute Pasteur, Paris, France, March 13, 1996, Hosted by the Laboratory of
Dr. Sandra Pellegrini.
Presentation at the XIth International Conference on Methods in Protein Structure Analysis,
September 1-5, 1996, Annecy, France.
Seminar at the Institute Cochin of Molecular Genetics, September 7, 1996, Paris, France.
Hosted by Dr. Siegmund Fischer.
Workshop on the WW Domain at The Rhone-Poulenc Rorer Pharmaceutical Company, Vitry-
Sur-Seine, September 8, 1996. This contact resulted in research collaboration between Mount
Sinai and RPR: supported by the RPR grant.
Speaker at the International Meeting on Oncogenes, “Oncogenes 20 Years After Discovery”,
organized by the Korean Society of Medical Biochemistry and Molecular Biology, October 30 -
November 1, 1996, Seoul Korea, Organizer: Dr. Jeong-Sun Seo.
Seminar at the Institute of Medical Sciences, University of Tokyo, November 3, 1996; Host:
Dr. Tadashi Yamamoto.

Seminar at the Nara Institute of Biotechnology, Nara, Kyoto, Japan, November 4, 1996.
Hosted by Dr. Tatsuo Takeya.
Speaker at the Annual Meeting of Cell Biology in Halle, Germany, March 16-20, 1997.
Organized by Dr. D. Glaser and Dr. J. Langner
Workshop on the WW domain and Alzheimer’s Disease at the Schering AG Company in
Berlin. Hosted by the Director of the Institute of Cell Biology and Molecular Medicine, Dr. Wolf-
Dieter Schleuning, March 23, 1997.
Seminar at the Pharmacological Institute of Berlin, Berlin, Germany. Hosted by Dr. Walter
Rosenthal and Dr. Hartmut Oschkinat, March 24, 1997.
Speaker at the International Meeting of Clinical Biology and Medicine “ClinBio Meeting” in
Naples, Italy. Organized by Drs. F. Salvatore and F. Cimino, November 6-9, 1997.
Speaker at the Institute of Cancer Research, Munster, Germany, Host: Dr. Angelika
Barnekow, April 17, 1998.
Presentation at the EMBL/SALK Meeting on Oncogenes, Heidelberg, Germany, April 18-23,
1998.
Presentation at the Institute of Medicine, April 25, 1998, Hannover, Germany, Host: Dr. H.
Niemann.
Seminar at Rhone-Poulenc Rorer Company, Vitry-Sur-Seine, France, Host: Dr. L. Mercken,
April 27, 1998.
Lecture at The National Cancer Institute, Madrid, Spain, Host: Dr. Mariano Barbacid. June 18,
1999.
Seminar at the University of Marseille, France. Host: Dr. Yves Collete, June 25, 1999.
Seminar at the Institute Pasteur, Immunology Department, Paris, France, Host: Dr. Oreste
Acuto, June 28, 1999.
Lecture at the University of Tokyo, Japan, Department of Neurology. Host: Dr. Hitoshi
Okazawa. May 8, 2000.
Seminar at the Institute of Medical Sciences, Meguro, Tokyo, Japan. Hosts: Drs. Tadashi
Yamamoto and Yuji Yamanashi. May 9, 2000.
Presentation at the Meeting on “Roles of Protein Tyrosine Phosphorylation in Signal
Transduction – The 25 th Anniversary of the c-Src Discovery”, May 10-12, 2000, Osaka Japan.
Organizer: Dr. Hisataka Sabe.
Lecture at the Biotechnology Center in Braunschweig, Germany. Host: Dr. Juergen Wehland.
May 22, 2000.
Seminar at the EMBL in Heidelberg. May 25, 2000. Hosts: Drs. Matti Saraste and Peer Bork.

Seminar at Genopole, Paris, on the “Proteomic Chips with WW domains”. October 24, 2000.
Hosts: Dr. Pierre Tambourin and Dr. Siegmund Fisher.
Seminar on ‘The WW domain of dystrophin; Signaling by dystrophin protein?” University of
Rome, Regina Elena, Host: Dr. Tamara Petrucci, October 26, 2000.
Plenary talk at International Meeting on “Decisions in the G1/M Cell Cycle Transition” Rome,
Italy. Organizers: Drs. Gianni Cesareni and Oreste Segatto. October 27-29, 2000.
International Meeting on Neuro-Degenerative Diseases, Nagoya, Japan, Organizer: Dr. M.
Takahashi, December 1, 2000.
Lecture at the University and Polytechnic CINESTAV of Mexico, Mexico City, March 9, 2001.
Host: Dr. Luis M. Salgado
Keynote Speaker for the European Seminar Series on Mapping the WW Domain in the
Human Proteome (7 presentations): AxCell and InforMax: May 2001. Seminars in Berlin,
Heidelberg, Munich, Amsterdam, Malmo, Manchester, London.
Keynote Speaker for the Asia Tour Seminar Series on Mapping the WW Domain in the
Human Proteome (4 presentations) in July 2001 with AxCell and InforMax: Taipei, Singapore,
Seoul, Tokyo.
Invited Research Seminar at Serono Company, Geneva, Switzerland, October 4, 2001. Host:
Dr. Robert Hooft.
International EURESCO Conference on Functional Protein Modules, Seefeld in Tirol, Austria,
October 6-11 2001. Organized by Drs. Mario Gimona and Matti Saraste. Co-chairman of the
session on WW domains and a speaker.
Seminar at Tokyo Metropolitan Institute for Neuroscience, May 7, 2002, Tokyo, Japan. Host:
Dr. Hitoshi Okazawa.
Lecture at the University of Tokyo, Department of Applied Biological Chemistry. May 8, 2002.
Host: Dr. Masaru Tanokura.
Oncogenes and Signaling, Rockefeller-Hanafusa Lab Alumni Meeting at the Osaka
Bioscience Institute. May 11, 2002. Seminar Speaker and Chairman.
Invited Speaker at the Fifteenth Annual Meeting of Japanese Association for Animal Cell
Technology, November 11-15, 2002 Fuchu, Tokyo, Japan
Invited Speaker at the EMBO/FEBS Meeting on Protein Modules in Gosau, Austria,
September 12-18, 2003
Seminar at McGill University Montreal, Canada October 7, 2003: Host: Dr. Xiang-Jiao Yang,
Ph.D.
Invited Speaker at the Human Proteome Organization Meeting in Montreal, Canada, October
8-11, 2003. At this meeting I have reported the first protein-protein interaction map of the
human protein module; a project completed by the AxCell Biotech Company in collaboration

with my laboratory.
Seminar At Lady Davis Jewish General Hospital, October 10, 2003. Host. Dr. Antonis
Koromilas.
Invited Speaker at the International Conference entitled “From Genomics to Medicine”,
University of Tokyo, Tokyo, Japan, November 28 and 29 th , 2003. Hosts: Drs. Kohtaro
Yamamoto and Hitoshi Okazawa.
Seminar at Weatherall Institute of Molecular Medicine, University of Oxford, U.K. April 18,
2005, Host: Dr. Stephan Feller
Seminar at the University of Tampere, Finland, April 22, 2005, Host: Dr. Kalle Saksela
Seminar at the University of Turku, Finland, April 25, 2005, Host: Dr. Klaus Elenius.
Speaker, chair and co-organizer of the FEBS workshop on Modular Protein Domains, Seefeld,
Austria, September 10-15, 2005, Hosts: Mario Gimona and Marius Sudol.
Seminar at the University of Ghent, Belgium, September 16, 2005, Hosts: Dr. Christophe
Ampe and Dr. Joel Vanderkeckhove.
Lecture at the University of Turku, Finland, October 28, 2005, Hosts: Dr. Marko Kallio and Dr.
Klaus Elenius.
Invited Lecture at the National Institute of Medical Research, London UK, October 18, 2006,
Host: Dr. Steven Gamblin.
Seminar at FMP (Forscungsinstitut fuer Moleculare Pharmacologie), Berlin, Germany.
October 20 th , 2006. Host: Dr. Hartmut Oschkinat.
Seminar at the Helmholtz Center for Research in Infectious Diseases, Braunschweig,
Germany, September 6, 2007. Hosts: Drs. Theresia Stradal and Juergen Wehland
Lecture and chairmanship of a session on Modular Domains that Bind Polyprolines.
September 11, 2007. Seefeld, Austria. Meeting organizers: Drs. Mario Gimona and Marius
Sudol.
Invited Lecture at the National Taiwan University in Taipei, Taiwan, October 17, 2007. Host:
Drs. Betty Wu and Fang-Jen S. Lee.
Invited Lecture at the National Cheng Kung University, Tainan, Taiwan, October 18, 2007.
Host: Dr. NanShan Chang.
Invited talk at the Eighth Cancer Cell Signaling Conference in Banff, Canada, March 9-13,
2008. Organizers: Drs. Tony Pawson, Steve Robbins and Andre Veillette.
Invited seminar at The University of Toronto, Canada. October 6, 2008. Host: Dr. Gary Bader.
Invited seminar at the Queen’s University, Kingston, Canada, October 7 th , 2008. Host: Drs.
Peter Greer and Richard Oko.

Invited seminar at the Montreal General Hospital, McGill University Health Centre, October 8 th ,
2008. Host: Dr. Danuta Radzioch.
Seminar at Tor Vergata University of Rome, Rome Italy, April 21, 2009. Host Dr. Gianni
Cesareni
Speaker and co-organizer of a workshop on the Newly Emerging Tumor Suppressor Pathway,
the HIPPO Pathway, April 22 and 23, 2009, Rome, Italy.
Presentation at the BIOS Conference 2009 at the University of Pisa, Italy, April 27, 2009.
Host: Dr. Luciana Dente.
Podium presentation and chairmanship of a session at the FEBS workshop on Modular
Protein Domains in Health and Disease, held in Seefeld, Austria from September 5-10, 2009;
(co-organized with Mario Gimona and Stephan Feller).
Podium presentation at “Annual International Conference: New Horizons of Molecular
Medicine” October 29 and 30th, 2009, Seoul, Korea. Invited by the leaders of the Korean
Society of Medical Biochemistry and Molecular Biology: Dr. Jeong-Sun Seo, Dr. Kyong Soo
Park and Dr. Hee-Young Chung.
Invited seminar at the Institute of Molecular and Cellular Biology A*STAR, Biopolis, Singapore,
November 4, 2009. Invited by Dr. Wanjin Hong.
Podium presentation at the Third Mechanobiology Workshop, November 5, 2009, National
University of Singapore. Invited by Dr. Michael Sheetz, Chair of the Organizing Committee.
Oral presentation at the Second Workshop on the Hippo Tumor Suppressor Pathway, Ariccia-
Rome, Italy, November 2-5, 2010, Invited by Dr. Giovanni Blandino.
Invited Seminar, University of Aberdeen, UK, September 13, 2011, Host: Dr. Henning
Wackerhage.
Talk and chairmanship at the FEBS Workshop on Protein Modules and Networks in Health
and Disease. September 14-18, 2007. Seefeld, Austria. Meeting organizers: Drs. Anne-
Claude Gavin, Marius Sudol and Giulio Superti-Furga.
Seminar at Laboratories-Fournier S.A., Abbott Company, Dijon, France, September 19, 2011.
Hosts: Drs. Laurent Chene and Pierre Broqua.
Seminar at the University of Alberta, Edmonton, Canada, May 18, 2012. Host: Dr. Shairaz
Baksh
Seminar at the McMaster University, Hamilton, Canada, August 31 st , 2012. Host: Dr. Andre
Bedard
Seminar at the University of Alberta, Vancouver, Canada, September 28, 2012. Host: Dr.
Colby Zaph

Invited talk at the “Molecular Structure and Function of the Apical Junctional Complex in
Epithelia and Endothelia”, Merida, Yucatan, Mexico, November 1-4, 2012. Host-Organizer:
Dr. Lorenza Gonzalez-Mariscal
Invited talk at the 6 th “Mechanobiology of Chromatin and Transcription” meeting. University of
Singapore, Republic of Singapore, November 12-14 th , 2012. Organizers Drs. L. Kenney, D.
Rhodes, G, Shivashankar, and Y. Jie.
Invited seminar at the IMCB-Biopolis, Republic of Singapore, November 15 th , 2012. Host: Dr.
Wan Jin Hong.
Invited talk at the Signaling Meeting in Sapporo, Japan, June 22-23, 2013. Host: Dr. Hisataka
Sabe
Invited seminar at OIST, Okinawa, Japan, June 28, 2013. Host: Dr. Tadashi Yamamoto
Invited seminar at the University of Osaka, Japan, June 29, 2013. Host: Dr. Sachiko Tsukita
Seminars and Lectureships at National Institutions. Most Presentations Were
on “The Role of the WW domain in Signaling and Disease” (1995-2009).
Wadsworth Science Center, Albany, New York. Host: Dr. Steve Hanes, August 16, 1995.
Ariad Biotechnology Company, Boston, Massachusetts, Host: Dr. Joan Brugge, February 28,
1996.
Frederick Meeting on Oncogenes, Frederick, Maryland, June 19-22, 1996.
Salk Meeting on Signaling and Tyrosine Phosphorylation, La Jolla, California, August 21-24,
1996.
Fox Chase Cancer Institute, Philadelphia, Pennsylvania, Host: Dr. Jonathan Chernoff.
September 25, 1996.
Hershey Medical Center, Hershey, Pennsylvania, Host: Dr. John Wills, September 26, 1996.
Regeneron Company, Tarrytown, New York. Host: Drs. David Glass and George Yancopolous
September 30, 1996.
University of North Carolina at Chapel Hill, Chapel Hill, NC. Host. Dr. Brian Kay, October 4 th ,
1996.
Yale University, New Haven, Connecticut, Department of Pharmacology, Host Dr. David
Stern, January 21, 1997.
Pearl River-Lederle Labs, Pearl River, New York, Host: Dr. Frank Loganzo, February 10,
1997.
Cytogen Pharmaceutical Company, Princeton, New Jersey, Host: Dr. Greg Pirozzi, March 7,
1997

University of California, Davis, California, Host: Dr. G. Gaava, August 14, 1997.
Salk Meeting on Oncogenes, La Jolla, California, Organizer: Dr. Tony Hunter, August 16-21,
1997.
Princeton University, Princeton, New Jersey, Department of Chemistry, Host Dr. Clarence
Shutt, September 11, 1997.
University of Texas, San Antonio, Texas, Department of Biochemistry, Host: Dr. Guy James,
October 24, 1997.
Albert Einstein College of Medicine, Department of Pharmacology. Dr. Michael Lisanti, March
2, 1998.
The Rockefeller University, Junior Faculty Seminar Series. Host: Dr. Ray Birge, March 11,
1998.
Hunter College, Department of Biochemistry, New York, Host. Dr. David Foster, May 22,
1998.
Meeting on Oncogenes and Signal Transduction, Salk Institute, La Jolla, June 17-20, 1998.
University of California at San Diego, California, Department of Mol. Biol. Host: Dr. X-D, Fu.
June 24, 1998.
Scripps Research Institute, La Jolla, California, Department of Biophysics and Chemistry.
Host: Dr. Jeff Kelly, October 9, 1998.
Signal Pharmaceuticals Company, San Diego, California, Host: Dr. Frank Mercurio, December
16, 1998.
Award Presentation: Research Grand Rounds at the Moffitt Cancer Center, Tampa, Florida.
Hosts: Drs. Rich Jove and Jack Pledger, February 11, 1999.
University of Maryland, Baltimore, Maryland. Department of Biochemistry, Host: Dr. Ricardo
Feldman, March 18, 1999.
Harvard Medical School, Department of Medicine, Host. Dr. Andrius Kazlaouskas, April 20,
1999.
Salt and Water Club Meeting Presentation, Philadelphia, October 2, 1999.
Alfred Du Pont Hospital for Sick Children, Wilmington Delaware, February 17, 2000, Host: Dr.
William Reenstra
University of West Virginia, Department of Molecular Biology, March 8, 2000, Host: Dr. Dan
Flynn.
Boheringer-Ingelheim Biotech Company, Connecticut, Department of Immunology. September
22, 2000. Host. Dr. Cheng-Kon Shih.

Tyrosine Phosphorylation Meeting, The Salk Institute, Oral Presentation, August 22, 2000.
Organizers: Drs. Bart Sefton and Tony Hunter.
AxCell Biosciences, Corporation, Newtown, PA. January, 2001. Host: Dr. John Rodwell.
University of Texas, Smithville, April 3, 2001. Host: Dr. Mark Bedford.
University of Washington, Seattle, April 19, 2001. Host: Dr. Stanley Fields.
University of California at San Francisco, April 20, 2001, Host: Dr. Caroline Damsky.
University of Wisconsin, Madison, April 24, 2001, Host: Dr. Emery Bresnick.
Plenary Lecture at the Genomics and Proteomics in Kidney and Urologic Diseases Meeting in
Washington D.C., July 8-10, 2001. Organized by NIH, NIDDK, Dr. Robert Star.
Case Western Reserve University, Cleveland, Ohio, October 18, 2001, Host: Dr. Hung-Ying
Kao.
Invited Seminar at UMDNJ-New Jersey, Newark, NJ, October 17, 2002, Host: Dr. Ray Birge.
Oral Presentation at the American Society of Nephrology Meeting, Section on Genomics and
Proteomics, Philadelphia, PA, November 1-4, 2002.
Oral Presentation at the American Society of Nephrology Meeting, Section on ENaC Sodium
Channel Regulation. Philadelphia, PA, November 1-4, 2002.
Boehringer Ingelheim Pharmaceuticals, Research Department, December 16, 2002, Host: Dr.
Hans Reiser.
Invited speaker at the FASEB Meeting, Tucson AZ, August 2-8, 2003, Receptor Protein-
Tyrosine Kinases, Organizers: Drs. David Stern and Carmen Birchmeier)
Albert Einstein School of Medicine, Department of Developmental & Molecular Biology,
September 9, 2003, Host: Dr. Richard Stanley.
National Cancer Institute, Lymphocyte Signaling Section, Frederick, MD. March 19, 2004.
Host: Dr. Daniel McVicar
Yale University School of Medicine, Department of Pathology, March 30, 2004. Host: Dr.
David Stern
Weis Center for Research, Danville, PA. April 29, 2004. Host: Dr. David Carey
Memorial Sloan-Kettering Cancer Center, New York, NY. May 27, 2004. Host: Dr. Chris
Sander
20 th Meeting on Oncogenes, Frederick, MD, June 18, 2004, Signaling Session: Chair: Dr.
David Foster

Seminar at Bucknell University, Lewisburg, PA, October 20 th , 2004, Host: Dr. Mitch Chernin.
Informal seminar at NIH, NIDCD, Bethesda, MD, October 6 th 2006. Host: Dr. Carter Van
Waes
Lecture at Susquehanna University, Selinsgrove, PA, February 20 th , 2007. Host: Dr. Tom
Peeler
Seminar at Department of Human Cancer Genetics at The Ohio State University, October 24,
2007. Host: Dr. Rami Aqeilan.
Informal seminar at the NIH, Bethesda, MD, December 5 th , 2007. Host: Dr. Carter Van Waes.
Seminar at the Greenebaum Cancer Center, University of Maryland, Baltimore, MD,
December 6 th , 2007. Host: Dr. Tony Passaniti.
Lecture at Susquehanna University, Selinsgrove, PA, March 25th, 2008. Host: Dr. Tom
Peeler
Seminar in the Windber Research Institute, Windber, PA, April 17 th , 2008. Host: Dr. Hai Hu.
Seminar at Albert Einstein College of Medicine, Bronx, New York, May 28 th , 2008. Host: Dr.
David Shafritz.
Invited Seminar at NIH, NIDCD, Bethesda, MD, June 17th, 2008. Host: Dr. Carter Van Waes.
Short talk at the 14th Conference of Protein Phosphorylation and Cell Signaling, The Salk
Institute, La Jolla, CA, August 15-19, 2008. Organizers: Drs. Sara Courtneidge and Tony
Hunter.
Seminar at the University of California in San Diego, CA, August 19 th , 2008. Host: Dr. Kun-
Liang Guan.
Seminar at the University of California at Irvine, CA, August 20th, 2008. Host: Dr. Robert
Steele.
Seminar at the Beckman Research Institute in the City of Hope National Medical Center,
Duarte, CA, August 21, 2008. Host: Dr. Richard Jove.
Seminar at the University of Miami Medical School, Miami, FL, April 3 rd . 2009. Host: Drs. Zafar
Nawaz and Ralf Landgraf.
Lecture at Susquehanna University, Selinsgrove, PA, April 14th, 2009. Host: Dr. Tom Peeler.
Seminar at the Moffitt Cancer Center, Tampa, FL, May 6 th , 2009. Host: Dr. Alvaro Monteiro.
Frontiers in Oncology Seminar at the University of Maryland School of Medicine, Baltimore,
MD, September 16, 2009. Host: Dr. Tony Passaniti.
Bortree Lecture at Penn State University, University Park, PA, October 14, 2009. Host: Dr.
Avery August.

Informal Seminar at the Wistar Institute, Philadelphia, May 6 th , 2010. Host: Dr. Joe Kissil.
Seminar at Cell Signaling Technology, Inc., in Danvers, MA, June 3 rd . 2010. Hosts: Drs. Peter
Hornbeck and Michael Comb.
Seminar at the University of Illinois at Chicago, Chicago, IL, May 11, 2011, Host: Dr. Maxim
Frolov.
Seminar at UMDNJ in Newark, NJ, October 28 th , 2011. Host: Dr. Junichi Sadoshima.
Seminar at Roswell Park Cancer Institute, Buffalo, NY, April 11, 2012. Host: Dr. Jianmin
Zhang.
Seminar at Memorial Sloan-Kettering Cancer Center, NYC, May 24 th , 2012. Host: Dr. Chris
Sander
Seminar at Penn State University, College of Medicine Hershey, PA, June 11, 2012. Host: Dr.
Gregory S. Yochum.
Planned: Seminar at Children’s Hospital in Boston, MA, April 19, 2013. Host: Dr. Fernando
Camargo
Planned: Seminar at Rosalind Franklin University of Medicine and Science, North Chicago, IL,
April 30, 2013. Host: Dr. Chao-Lan Yu.
Presentation at Keystone Symposia on Hippo Tumor Suppressor Pathway, Monterey,
California, May 22, 2013. Organizers: Drs. Helen McNeill, Georg Halder, Giovanni Blandino
and Marius Sudol.

General references for Marius Sudol
Dr. Peter K. Vogt
Dr. Tony Hunter
Dr. Paul Greengard
Dr. Giulio Superti-Furga
**********************************************************
Dr. Peter K. Vogt, Professor
The Scripps Research Institute
BCC 239
10550 N Torrey Pines Rd.
La Jolla, CA 92037
e. mail: pkvogt@scripps.edu
Dr. Tony Hunter, Professor
The Salk Institute
Mol. Biol. & Virology Lab
P.O. Box 85800
10010 N. Torrey Pines Rd.
La Jolla, CA 92037-1099
e.mail: hunter@salk.edu
Dr. Paul Greengard, Professor
Laboratory of Molecular and Cellular Neuroscience
The Rockefeller University
1230 York Avenue, New York, NY 10021
e.mail: greengd@rockvax.rockefeller.edu
Dr. Giulio Superti-Furga, Ph.D.
Scientific Director
CeMM
Research Center for Molecular Medicine
of the Austrian Academy of Sciences
Lazarettgasse 14, AKH BT 25.3
1090 Vienna, Austria
e-mail: gsuperti@cemm.oeaw.ac.at